Provectus Biopharmaceuticals Inc (PVCT)
0.194
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Provectus Biopharmaceuticals Total Assets (Quarterly): 1.449M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.449M |
| September 30, 2023 | 1.690M |
| June 30, 2023 | 1.687M |
| March 31, 2023 | 1.720M |
| December 31, 2022 | 2.037M |
| September 30, 2022 | 2.050M |
| June 30, 2022 | 2.443M |
| March 31, 2022 | 2.756M |
| December 31, 2021 | 3.513M |
| September 30, 2021 | 0.6003M |
| June 30, 2021 | 0.4663M |
| March 31, 2021 | 0.7714M |
| December 31, 2020 | 0.5892M |
| September 30, 2020 | 1.345M |
| June 30, 2020 | 1.839M |
| March 31, 2020 | 0.82M |
| December 31, 2019 | 1.477M |
| September 30, 2019 | 1.564M |
| June 30, 2019 | 2.718M |
| March 31, 2019 | 3.692M |
| December 31, 2018 | 1.988M |
| September 30, 2018 | 2.422M |
| June 30, 2018 | 3.526M |
| March 31, 2018 | 3.058M |
| December 31, 2017 | 3.436M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.852M |
| June 30, 2017 | 4.929M |
| March 31, 2017 | 4.510M |
| December 31, 2016 | 5.611M |
| September 30, 2016 | 10.69M |
| June 30, 2016 | 10.83M |
| March 31, 2016 | 16.02M |
| December 31, 2015 | 20.44M |
| September 30, 2015 | 26.60M |
| June 30, 2015 | 31.24M |
| March 31, 2015 | 22.77M |
| December 31, 2014 | 26.18M |
| September 30, 2014 | 21.65M |
| June 30, 2014 | 22.10M |
| March 31, 2014 | 20.79M |
| December 31, 2013 | 20.01M |
| September 30, 2013 | 12.78M |
| June 30, 2013 | 9.373M |
| March 31, 2013 | 9.272M |
| December 31, 2012 | 6.204M |
| September 30, 2012 | 7.010M |
| June 30, 2012 | 9.466M |
| March 31, 2012 | 10.45M |
| December 31, 2011 | 13.35M |
| September 30, 2011 | 16.67M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.4663M
Minimum
Jun 2021
3.513M
Maximum
Dec 2021
1.660M
Average
1.687M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Insmed Inc | 1.330B |
| NeuroMetrix Inc | 21.42M |
| Intra-Cellular Therapies Inc | 728.30M |
| Rhythm Pharmaceuticals Inc | 332.74M |
| Amylyx Pharmaceuticals Inc | 517.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.042M |
| Shareholders Equity (Quarterly) | -7.593M |